These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 28990054)
21. Identification of a five-lncRNA signature for the diagnosis and prognosis of gastric cancer. Fan ZY; Liu W; Yan C; Zhu ZL; Xu W; Li JF; Su L; Li C; Zhu ZG; Liu B; Yan M Tumour Biol; 2016 Oct; 37(10):13265-13277. PubMed ID: 27460075 [TBL] [Abstract][Full Text] [Related]
22. Serum galectin-3 as a potential marker for gastric cancer. Cheng D; Liang B; Li Y Med Sci Monit; 2015 Mar; 21():755-60. PubMed ID: 25765552 [TBL] [Abstract][Full Text] [Related]
23. Serum CXCL13 and PECAM-1 can be used as diagnostic and prognostic markers in elderly patients with gastric cancer. Li Y; Guo XB; Wei YH; Kang XL Clin Transl Oncol; 2021 Jan; 23(1):130-138. PubMed ID: 32500259 [TBL] [Abstract][Full Text] [Related]
24. Decreased long noncoding RNA MIR31HG is correlated with poor prognosis and contributes to cell proliferation in gastric cancer. Nie FQ; Ma S; Xie M; Liu YW; De W; Liu XH Tumour Biol; 2016 Jun; 37(6):7693-701. PubMed ID: 26692098 [TBL] [Abstract][Full Text] [Related]
25. Diagnostic and prognostic role of serum protein peak at 6449 m/z in gastric adenocarcinoma based on mass spectrometry. Song D; Yue L; Li H; Zhang J; Yan Z; Fan Y; Yang H; Liu Q; Zhang D; Xia Z; Qin P; Jia J; Yue M; Yu J; Zheng S; Yang F; Wang J Br J Cancer; 2016 Apr; 114(8):929-38. PubMed ID: 27002935 [TBL] [Abstract][Full Text] [Related]
26. TMEM16A overexpression contributes to tumor invasion and poor prognosis of human gastric cancer through TGF-β signaling. Liu F; Cao QH; Lu DJ; Luo B; Lu XF; Luo RC; Wang XG Oncotarget; 2015 May; 6(13):11585-99. PubMed ID: 25839162 [TBL] [Abstract][Full Text] [Related]
27. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer. Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496 [TBL] [Abstract][Full Text] [Related]
28. High expression of long non-coding RNA CCAT2 indicates poor prognosis of gastric cancer and promotes cell proliferation and invasion. Wu SW; Hao YP; Qiu JH; Zhang DB; Yu CG; Li WH Minerva Med; 2017 Aug; 108(4):317-323. PubMed ID: 28248065 [TBL] [Abstract][Full Text] [Related]
29. CtBP2 overexpression promotes tumor cell proliferation and invasion in gastric cancer and is associated with poor prognosis. Dai F; Xuan Y; Jin JJ; Yu S; Long ZW; Cai H; Liu XW; Zhou Y; Wang YN; Chen Z; Huang H Oncotarget; 2017 Apr; 8(17):28736-28749. PubMed ID: 28404932 [TBL] [Abstract][Full Text] [Related]
30. Combination of miRNA and RNA functions as potential biomarkers for gastric cancer. Chen S; Zhu J; Yu F; Tian Y; Ma S; Liu X Tumour Biol; 2015 Dec; 36(12):9909-18. PubMed ID: 26168960 [TBL] [Abstract][Full Text] [Related]
31. Rs41291957 polymorphism in the promoter region of microRNA‑143 serves as a prognostic biomarker for patients with intracranial hemorrhage. Yang X; Guo Z; Cao F; Teng Z; Huang Z; Sun X Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33649782 [TBL] [Abstract][Full Text] [Related]
32. CD147 overexpression may serve as a promising diagnostic and prognostic marker for gastric cancer: evidence from original research and literature. Hu C; Dong X; Wu J; Xiao F; Shang J; Liu L; Yang Y; Luo D; Li Q; Song Q; Yang J; Zhang C; Shen L; Luo Z Oncotarget; 2017 May; 8(19):30888-30899. PubMed ID: 28427166 [TBL] [Abstract][Full Text] [Related]
33. Integrating trans-omics, cellular experiments and clinical validation to identify ILF2 as a diagnostic serum biomarker and therapeutic target in gastric cancer. Liu SS; Wan QS; Lv C; Wang JK; Jiang S; Cai D; Liu MS; Wang T; Zhang KH BMC Cancer; 2024 Apr; 24(1):465. PubMed ID: 38622522 [TBL] [Abstract][Full Text] [Related]
34. Expression and prognostic value of microRNA-26a and microRNA-148a in gastric cancer. Qiu X; Zhu H; Liu S; Tao G; Jin J; Chu H; Wang M; Tong N; Gong W; Zhao Q; Qiang F; Zhang Z J Gastroenterol Hepatol; 2017 Apr; 32(4):819-827. PubMed ID: 27529338 [TBL] [Abstract][Full Text] [Related]
35. The association of interleukin-16 polymorphisms with IL-16 serum levels and risk of colorectal and gastric cancer. Gao LB; Rao L; Wang YY; Liang WB; Li C; Xue H; Zhou B; Sun H; Li Y; Lv ML; Du XJ; Zhang L Carcinogenesis; 2009 Feb; 30(2):295-9. PubMed ID: 19073878 [TBL] [Abstract][Full Text] [Related]
36. Pituitary tumor-transforming gene-1 serves as an independent prognostic biomarker for gastric cancer. Xu MD; Dong L; Qi P; Weng WW; Shen XH; Ni SJ; Huang D; Tan C; Sheng WQ; Zhou XY; Du X Gastric Cancer; 2016 Jan; 19(1):107-15. PubMed ID: 25627474 [TBL] [Abstract][Full Text] [Related]
37. Tumor apelin, not serum apelin, is associated with the clinical features and prognosis of gastric cancer. Feng M; Yao G; Yu H; Qing Y; Wang K BMC Cancer; 2016 Oct; 16(1):794. PubMed ID: 27733135 [TBL] [Abstract][Full Text] [Related]
38. Serum IL-17 levels can be diagnostic for gastric cancer. Karabulut M; Usul Afsar C; Serimez M; Karabulut S J BUON; 2019; 24(4):1601-1609. PubMed ID: 31646815 [TBL] [Abstract][Full Text] [Related]
39. Function and diagnostic value of Anosmin-1 in gastric cancer progression. Kanda M; Shimizu D; Fujii T; Sueoka S; Tanaka Y; Ezaka K; Takami H; Tanaka H; Hashimoto R; Iwata N; Kobayashi D; Tanaka C; Yamada S; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y Int J Cancer; 2016 Feb; 138(3):721-30. PubMed ID: 26270236 [TBL] [Abstract][Full Text] [Related]
40. FOXQ1 promotes gastric cancer metastasis through upregulation of Snail. Zhang J; Liu Y; Zhang J; Cui X; Li G; Wang J; Ren H; Zhang Y Oncol Rep; 2016 Jun; 35(6):3607-13. PubMed ID: 27109028 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]